Absci Corp (ABSI)
5.18
+0.42
(+8.82%)
USD |
NASDAQ |
May 01, 16:00
5.18
0.00 (0.00%)
After-Hours: 20:00
Absci Revenue (TTM): 5.718M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.718M |
| September 30, 2023 | 6.937M |
| June 30, 2023 | 8.562M |
| March 31, 2023 | 6.197M |
| December 31, 2022 | 5.747M |
| September 30, 2022 | 5.642M |
| June 30, 2022 | 4.812M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.538M |
| December 31, 2021 | 4.782M |
| September 30, 2021 | 6.058M |
| June 30, 2021 | 5.435M |
| March 31, 2021 | 5.271M |
| December 31, 2020 | 4.78M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.538M
Minimum
Mar 2022
8.562M
Maximum
Jun 2023
5.729M
Average
5.642M
Median
Sep 2022
Revenue (TTM) Benchmarks
| Amgen Inc | 28.19B |
| Eli Lilly and Co | 34.12B |
| Creative Medical Technology Holdings Inc | -- |
| HOOKIPA Pharma Inc | 20.13M |
| Recursion Pharmaceuticals Inc | 43.88M |